The recent analytical report published by Markntel Advisors (a leading consulting, data analytics, and market research firm), Spinal Muscular Atrophy (SMA) Treatment Market comprises a detailed study of critical and major aspects of market dynamics, i.e. market trends, size, forecasts, growth factors, challenges, and competitor landscape.
In-Depth Market Overview of Spinal Muscular Atrophy (SMA) Treatment Industry (2025-2030):
According to the latest report, The Spinal Muscular Atrophy (SMA) Treatment Market size was valued at around USD 2.3 billion in 2023 and is projected to reach around USD 30.2 billion by 2030. Along with this, the market is anticipated to grow at a CAGR of around 18.2% during the forecast period, i.e., 2025-30. The report demonstrates the prominent factors propelling the exponential growth of the Spinal Muscular Atrophy (SMA) Treatment industry.
Key Takeaways: Beneficial for Stakeholders and Clients:
· Historical Data: 2020-23
· Base Year: 2024
· Forecast Period: 2025-30
· CAGR – 18.2%
· Market Value in 2023: USD 2.3 Billion
· Market Value in 2030: USD 30.2 Billion
What are the major Driver the global Spinal Muscular Atrophy (SMA) Treatment industry?
Growing Incidence of the Disorder to Augment the Market – In terms of cost and healthcare services, the overall burden of spinal muscular atrophy is one of the highest in the rare disorder. With multiple incidences of spinal muscular atrophy popping up due to the increase in population, the requirement for SMA treatment is growing drastically on a global level. As per the Spinal Muscular Atrophy Foundation estimations, 1 in every 6000 to 10000 babies are diagnosed with this, despite being considered a rare disorder. Thus the rising rampancy of this disorder is one of the major factors that increases revenue generation from the market. Moreover, the rising awareness regarding novel therapies and the increasing number of product launches are some of the major factors deriving market growth. The high need for quality treatment options coupled with the awareness about the lethal backlash of the disorder will significantly aid in the development of the market.
Download a sample PDF of this report to gain insights into the complete report structure - https://www.marknteladvisors.com/query/request-sample/spinal-muscular-atrophy-sma-treatment-market.html
Spinal Muscular Atrophy (SMA) Treatment Market Segmentation
The Spinal Muscular Atrophy (SMA) Treatment Market analysis of Markntel Advisors explores the industry by emphasizing the growth parameters and categorizes including geographical segmentation, to offer a comprehensive understanding of the market dynamic. The further bifurcations are as follows:
- By Type
- Type I- Market Size & Forecast 2020-2030, USD Million
- Type II- Market Size & Forecast 2020-2030, USD Million
- Type III- Market Size & Forecast 2020-2030, USD Million
- Type IV- Market Size & Forecast 2020-2030, USD Million
- By Treatment
- Gene Therapy- Market Size & Forecast 2020-2030, USD Million
- Disease-Modifying Drugs- Market Size & Forecast 2020-2030, USD Million
- By Drug Type
- Nusinersen- Market Size & Forecast 2020-2030, USD Million
- Onasemnogene Abeparvovec- Market Size & Forecast 2020-2030, USD Million
- Others- Market Size & Forecast 2020-2030, USD Million
- By Route of Administration
- Oral- Market Size & Forecast 2020-2030, USD Million
- Injectable- Market Size & Forecast 2020-2030, USD Million
- By Distribution Channel
- Hospital Pharmacies- Market Size & Forecast 2020-2030, USD Million
- Retail Pharmacies- Market Size & Forecast 2020-2030, USD Million
- Online Pharmacies- Market Size & Forecast 2020-2030, USD Million
- By End User
- Hospitals- Market Size & Forecast 2020-2030, USD Million
- Homecare- Market Size & Forecast 2020-2030, USD Million
- Specialty Clinics- Market Size & Forecast 2020-2030, USD Million
- Others- Market Size & Forecast 2020-2030, USD Million
- By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
As per the regional aspect, the Spinal Muscular Atrophy (SMA) Treatment Market is expected to be dominated by North America by capturing the potential market share.
Explore further details about this research report - https://www.marknteladvisors.com/research-library/spinal-muscular-atrophy-sma-treatment-market.html
Top Companies in the Spinal Muscular Atrophy (SMA) Treatment Market
Biogen, Novartis AG, F. Hoffmann-La Roche Ltd, Cytokinetics, PTC Therapeutics, Inc, Ionis Pharmaceuticals Inc., Astellas Pharma Inc., NMD Pharma A/S, Genzyme Corporation, Genentech, Inc., Pfizer Inc., Scholar Rock Holding Corporation, Novo Nordisk A/S, Takeda Pharmaceutical Co. Ltd, and others
Global Spinal Muscular Atrophy (SMA) Treatment Industry Recent Development:
October 2024: Biogen Inc. reported data concerning the efficacy of nusinersen under the higher dose regimen from Parts B and C of the DEVOTE combined Phase 2/3 trial for infantile-onset, as well as later-onset spinal muscular atrophy in pre-treated-and-untreated-patients.
March 2023, innovation in Zolgensma®, female name onasemnogene abeparvovec, was claimed by Novartis as a fitting one-time gene therapy essential for spinal muscular atrophy.
Why Markntel Advisors Report?
Well-known business Prospects: Our accurate analysis market research report serves as a treasure map for discovering potential markets and novel product avenues. Additionally, it facilitates comprehensive comparisons of products and services.
Thoughtful Customer Insights: A market report provides the marketing department with an in-depth understanding of customer requirements and desires. This information is bound to enhance products, adjust pricing, and refine advertising strategies.
Empowering Data-Backed Judgement: Our comprehensive Market research encompasses a wide spectrum of activities, including precise market sizing, detailed segment analysis, accurate demand forecasting, competitor identification, and meticulous pricing trend monitoring.
Need personalized insights? Click here to customize this report- https://www.marknteladvisors.com/query/request-customization/spinal-muscular-atrophy-sma-treatment-market.html
For Further Queries:
Contact Us
MarkNtel Advisors
+1 628 895 8081, +91 120 4278433
Corporate Office: Office No.109,
H-159, Sector 63, Noida, Uttar Pradesh - 201301, India
